West Pharmaceutical Services Schedules September Investor Presentations
Executives from Exton-based West Pharmaceutical Services will outline the company’s strategic trajectory at two major healthcare forums this September. The manufacturer, which reported $3.07 billion in net sales for fiscal 2025, intends to discuss its role in the global injectable drug delivery market during back-to-back industry conferences.
The company’s leadership team is slated to present at the Wells Fargo Annual Healthcare Conference in Everett, Massachusetts, on September 10 at 8:45 a.m. EDT. This appearance will be followed by a presentation at the Morgan Stanley Annual Global Healthcare Conference in New York on September 14 at 8:30 a.m. EDT. Investors and industry analysts can access live webcasts through the company’s portal, with archived replays remaining available for 90 days following each session.
West currently operates a network of 50 sites worldwide, including 26 manufacturing facilities, and produces over 41 billion components and devices annually. As a component of the S&P 500, the firm remains a critical link for both established pharmaceutical companies and emerging drug developers focused on the containment and administration of injectable therapies.
Comments (0)
No comments yet. Be the first!